Journal article
Persistence and adherence to cholesterol lowering agents: Evidence from Régie de l'Assurance Maladie du Québec data
Abstract
BACKGROUND: There is a concern that poor compliance to cholesterol lowering agents (CLA) may compromise their potential benefits. The objective of this study was to estimate compliance to CLAs, in the context of clinical practice in Quebec.
METHODS: This study was performed using data from the Régie de l'Assurance Maladie du Québec Persistence and adherence to treatment were estimated separately. An index combining these 2 measures was also …
Authors
Lachaine J; Rinfret S; Merikle EP; Tarride J-E
Journal
American Heart Journal, Vol. 152, No. 1, pp. 164–169
Publisher
Elsevier
Publication Date
7 2006
DOI
10.1016/j.ahj.2005.09.010
ISSN
0002-8703
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overAnticholesteremic AgentsAtorvastatinCoronary DiseaseDatabases, FactualFatty Acids, MonounsaturatedFemaleFluvastatinHeptanoic AcidsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIndolesLovastatinMaleMiddle AgedPatient CompliancePravastatinPyrrolesQuebecRegistriesRetrospective StudiesSimvastatin